Core Scientific stock tests $18.94 resistance after $600 million credit facilities secured

Traders Union
All News
Stocks
Core Scientific jumps 3.5% to $18.03

Highlights

Core Scientific secured $600 million in senior secured credit facilities, strengthening liquidity and financial flexibility for the company.
The completed $444 million all-cash acquisition of Polaris DS expands Core Scientific’s asset base and operational reach.
CORZ stock trades in a volatile $17.12 to $18.94 range, showing mixed momentum signals and potential for near-term consolidation.

Liquidity improves as credit facility and acquisition spur optimism

Core Scientific has secured $600 million in committed senior secured credit facilities, including a $100 million revolving credit facility and a $500 million letter of credit facility, according to Investingnews. This substantial capital commitment immediately boosts the company’s liquidity and enhances its financial flexibility, fostering increased investor demand for CORZ stock. In addition, the recently completed $444 million all-cash acquisition of Polaris DS expands Core Scientific’s asset base and positions the company for further operational synergies, supporting the positive fundamentals reflected in the current move.

Mixed momentum as price straddles key technical levels

The $18.03 price sits above the MA-20 at $17.67 but below the MA-50 at $18.15 and well under the MA-200 of $19.69. The Ichimoku Kijun at $17.67 acts as the nearest support. Momentum signals present a mixed picture: MACD is in Sell, ADX remains Neutral, RSI is at 40.08, while both Stoch RSI and CCI show Sell signals. However, Bull/Bear Power stands in Buy mode, highlighting net intraday buying interest despite generally bearish momentum.

Range-bound trade expected as breakout risks remain balanced

Looking ahead to the next 2–3 trading days, the base case is for CORZ to consolidate between $17.12 and $18.94, with a 53% probability of an upside move and a 47% likelihood of a retracement. Price action within this volatility band is most probable unless a significant breakout above resistance or a decisive breakdown below support occurs.

Viktoras Karapetjanc, expert at Traders Union, believes the recent $600 million capital commitment is a strong fundamental catalyst for Core Scientific. He sees improved financial flexibility and a bigger asset base as drivers for heightened investor interest. Despite mixed technical signals, the liquidity boost and recent acquisition support a positive near-term bias. He expects the stock to consolidate with an upside tilt unless key levels are broken. "CORZ’s fundamentals are turning decisively favorable, and I see this liquidity injection keeping positive sentiment alive in the short term."

Previously it was reported that Core Scientific shares were under pressure due to persistent technical weakness and disappointing earnings, with recovery hinging on overcoming key resistance levels. The current article adds a positive dimension by highlighting fresh capital commitments and a strategic acquisition, making the $18.94 resistance the immediate level to watch for any breakout-driven upside.

Source of Data: CORZ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.